LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Home・Aktien・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Geschlossen

BrancheGesundheitswesen

38.75 -2.69

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

38.45

Max

39.57

Schlüsselkennzahlen
By Trading Economics
Einkommen	11M 51M
Verkäufe	39M 239M
KGV Branchendurchschnitt	11.202 80.03
EPS	1.08
Gewinnspanne	21.242
Angestellte	268
EBITDA	14M 73M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+15.49% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	358M 2B
Vorheriger Eröffnungskurs	41.44
Vorheriger Schlusskurs	38.75

Nachrichtenstimmung

By Acuity

50%

166 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

29.8 / N/A Unterstützung & Widerstand

Harmony Biosciences Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Dez. 2025, 23:48 UTC

Wichtige Markttreiber

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8. Dez. 2025, 23:44 UTC

Market Talk

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8. Dez. 2025, 23:42 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8. Dez. 2025, 23:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Dez. 2025, 23:13 UTC

Market Talk

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8. Dez. 2025, 23:09 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8. Dez. 2025, 22:46 UTC

Market Talk

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8. Dez. 2025, 22:01 UTC

Market Talk

Miners Poised to Do Well in 2026 -- Market Talk

8. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8. Dez. 2025, 21:51 UTC

Market Talk

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8. Dez. 2025, 21:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

8. Dez. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Dez. 2025, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8. Dez. 2025, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8. Dez. 2025, 21:36 UTC

Market Talk

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8. Dez. 2025, 21:20 UTC

Akquisitionen, Fusionen, Übernahmen

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8. Dez. 2025, 21:12 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8. Dez. 2025, 21:08 UTC

Market Talk

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8. Dez. 2025, 20:38 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8. Dez. 2025, 20:26 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8. Dez. 2025, 20:18 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8. Dez. 2025, 20:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8. Dez. 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8. Dez. 2025, 20:05 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Dez. 2025, 20:05 UTC

Market Talk

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8. Dez. 2025, 20:01 UTC

Market Talk

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Peer-Vergleich

Kursveränderung

Harmony Biosciences Holdings Inc Prognose

Kursziel

By TipRanks

15.49% Vorteil

12-Monats-Prognose

Durchschnitt 46 USD 15.49%

Hoch 62 USD

Tief 32 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Harmony Biosciences Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Harmony Biosciences Holdings Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

29.8 / N/AUnterstützung & Widerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Stimmung

By Acuity

166 / 374 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.